Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,080 | -33,294 | -22,612 | -13,268 | -2,595 |
| Depreciation Amortization | 210 | -7,026 | -7,247 | -7,480 | -7,748 |
| Accounts receivable | N/A | N/A | -147 | -221 | 3 |
| Accounts payable and accrued liabilities | -282 | 371 | -19 | 291 | -190 |
| Other Working Capital | -567 | 1,229 | 393 | 310 | -1,734 |
| Other Operating Activity | 1,209 | 5,631 | 5,083 | 3,721 | 3,035 |
| Operating Cash Flow | $-10,510 | $-33,089 | $-24,549 | $-16,647 | $-9,229 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,650 | -10,245 | -9,265 | -8,085 | -6,125 |
| PPE Investments | N/A | -54 | -45 | -40 | -16 |
| Investing Cash Flow | $2,650 | $-10,299 | $-9,310 | $-8,125 | $-6,141 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -23 | -85 | -63 | -42 | -21 |
| Common Stock Issued | 47 | 49,037 | 49,037 | 49,054 | 0 |
| Financing Cash Flow | $24 | $48,952 | $48,974 | $49,012 | $-21 |
| Beginning Cash Position | 63,745 | 58,181 | 58,181 | 58,181 | 58,181 |
| End Cash Position | 55,909 | 63,745 | 73,296 | 82,421 | 42,790 |
| Net Cash Flow | $-7,836 | $5,564 | $15,115 | $24,240 | $-15,391 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,510 | -33,089 | -24,549 | -16,647 | -9,229 |
| Capital Expenditure | 0 | -54 | -45 | -40 | -16 |
| Free Cash Flow | -10,510 | -33,143 | -24,594 | -16,687 | -9,245 |